High incidence of topical allergic reactions to 1% apraclonidine.
D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D003000:Clonidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D015994:Incidence; D007429:Intraocular Pressure; D009883:Ophthalmic Solutions
D000316:Adrenergic alpha-Agonists; D009883:Ophthalmic Solutions; C016986:apraclonidine; D003000:Clonidine